Medical Devices: Page 52
-
Elon Musk’s brain implant company raises $280M to fund clinical trials
Peter Thiel's venture capital firm led the investment weeks after Neuralink secured clearance to study its device in humans.
By Nick Paul Taylor • Aug. 9, 2023 -
Guardant, Illumina agree to end litigation, extend commercial partnership
The two sides will now renew a long-term collaboration to advance cancer research, Guardant said.
By Susan Kelly • Aug. 8, 2023 -
Explore the Trendline➔
Sara Silbiger via Getty ImagesTrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Abbott lands FDA clearance of Alinity complete blood count system
The company claims the device uses less floor space and has one of the highest throughputs as it competes with diagnostic systems made by Beckman Coulter and Siemens Healthineers.
By Nick Paul Taylor • Aug. 8, 2023 -
Appeals court overturns ruling in Axonics-Medtronic neurostim patent dispute
The court said the patent board’s “refusal to consider the new arguments and evidence was erroneous.”
By Nick Paul Taylor • Aug. 8, 2023 -
J&J subsidiary gains approval for heart ablation devices to use without fluoroscopy
The expanded label could limit exposure to radiation while patients are treated for heart arrhythmias.
By Elise Reuter • Aug. 7, 2023 -
Medtronic expected to prevail at FDA renal denervation vote despite data doubts: analysts
Needham analysts predict the experts will vote in favor of Medtronic and put the device on track to target a $1 billion-plus market.
By Nick Paul Taylor • Aug. 7, 2023 -
Anne-Françoise Nesmes to step down as Smith+Nephew CFO next year
The announcement comes as Smith+Nephew raised its forecast for the year to a 6% to 7% revenue increase, due to more favorable market conditions.
By Nick Paul Taylor • Aug. 7, 2023 -
Stryker raises earnings forecast as procedures return to pre-pandemic levels
The company expects elevated procedure demand to continue into 2024 due to surgery backlogs.
By Elise Reuter • Aug. 4, 2023 -
Q&A: How Monogram’s CEO plans to disrupt robotic joint replacement surgery
The robot developer’s CEO, Benjamin Sexson, tells MedTech Dive why he believes the orthopedics market needs a fresh approach to joint reconstruction.
By Susan Kelly • Aug. 4, 2023 -
Penumbra says stroke device delayed at least 12 months due to FDA request
The setback stalls “a meaningful new product catalyst,” but the growth of Penumbra’s other devices could cushion the impact, analysts said.
By Nick Paul Taylor • Aug. 4, 2023 -
Outset pauses shipments of dialysis accessory after FDA warning letter, denting sales outlook
The halt prompted the company to predict it will now hit the bottom end of its full-year revenue range, a revision that surprised some analysts.
By Nick Paul Taylor • Aug. 4, 2023 -
BD prepares for relaunch of Alaris pump, raises revenue forecast
The pump relaunch isn’t expected to contribute much to this year’s revenue, but could help Becton Dickinson reach its long-term financial goals.
By Elise Reuter • Aug. 3, 2023 -
CMS inpatient final rule will have muted impact on medtech companies, analysts say
The CMS disclosed add-on payments that will continue in 2024 and named products that received approval under the breakthrough devices pathway.
By Nick Paul Taylor • Aug. 3, 2023 -
Baxter recalls infusion pumps over risk of false alarms
Baxter made a software fix last year after it found pumps weren't issuing an occlusion alarm. Now, the devices might issue alarms even when there isn't a blockage.
By Elise Reuter • Aug. 2, 2023 -
Cooper scraps $875M takeover of Cook Medical business after FTC investigation
The FTC said ending the planned acquisition “ensures that critical reproductive health markets remain competitive.”
By Nick Paul Taylor • Aug. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Varian logistics slow growth at Siemens Healthineers in Q3
Healthineers has worked through some logistics problems but now faces a race to install Varian equipment at customer sites.
By Nick Paul Taylor • Aug. 2, 2023 -
Terumo receives FDA clearance for automated whole blood processing system
The device automates additional steps needed to separate platelets from the rest of the blood, giving blood centers more capacity.
By Elise Reuter • Aug. 1, 2023 -
Abbott pulls Trifecta heart valves from US market over deterioration rate
The action removes a rival to Edwards Lifesciences and Medtronic for the surgical aortic valve replacement market.
By Nick Paul Taylor • Aug. 1, 2023 -
Vicarious expects to perform first human procedure with robot next year
The company, after disclosing layoffs in February, said it has gained clarity on its regulatory pathway following pre-submission meetings with the FDA.
By Susan Kelly • July 31, 2023 -
Integra warns impact of plant closure will continue into 2024, with delays possible
Management has built a buffer into the plan but cautioned unforeseen events could cause its timeline to slip.
By Nick Paul Taylor • July 31, 2023 -
GE HealthCare oxygen sensor recall gets Class I label from FDA
GE warned that the sensors can limit the effectiveness of cardiac defibrillation, expose patients to electrical currents, or give inaccurate blood oxygen readings.
By Nick Paul Taylor • July 31, 2023 -
Thermo Fisher eyes $450M in cost cuts due to slowing demand
The pullback in spending will include layoffs and lower investments in some areas of the business, company executives said.
By Susan Kelly • July 28, 2023 -
FDA shares draft guidance on studying medtech treatments for opioid use disorder
The FDA aims to address challenges including inaccurate self-reported drug use, missing data and the need to show the durability of the treatment.
By Nick Paul Taylor • July 28, 2023 -
Dexcom hails CGM share gains as driver of 25% revenue growth in Q2
International market share gains and expanding coverage in the U.S. led the CGM maker to raise its revenue forecast for 2023.
By Nick Paul Taylor • July 28, 2023 -
Abbott recall of heart catheter categorized as Class I event
Abbott plans to win approval for a modified steerable product and bring it to market as a replacement for the recalled device.
By Nick Paul Taylor • July 27, 2023